CH485752A - Process for the preparation of basic substituted heterocycles - Google Patents
Process for the preparation of basic substituted heterocyclesInfo
- Publication number
- CH485752A CH485752A CH1011567A CH1011567A CH485752A CH 485752 A CH485752 A CH 485752A CH 1011567 A CH1011567 A CH 1011567A CH 1011567 A CH1011567 A CH 1011567A CH 485752 A CH485752 A CH 485752A
- Authority
- CH
- Switzerland
- Prior art keywords
- sep
- formula
- acid
- preparation
- dibenzo
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 4
- 125000000623 heterocyclic group Chemical group 0.000 title description 2
- 239000002253 acid Substances 0.000 claims description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- UZVGSSNIUNSOFA-UHFFFAOYSA-N dibenzofuran-1-carboxylic acid Chemical compound O1C2=CC=CC=C2C2=C1C=CC=C2C(=O)O UZVGSSNIUNSOFA-UHFFFAOYSA-N 0.000 claims description 4
- 150000001412 amines Chemical class 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 2
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 2
- 150000004885 piperazines Chemical class 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 125000004434 sulfur atom Chemical group 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 1
- 239000007795 chemical reaction product Substances 0.000 claims 1
- 239000012458 free base Substances 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 150000007522 mineralic acids Chemical class 0.000 claims 1
- 150000007524 organic acids Chemical class 0.000 claims 1
- 235000005985 organic acids Nutrition 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000003951 lactams Chemical class 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000003474 anti-emetic effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- -1 methoxy, thiomethyl Chemical group 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 229940125683 antiemetic agent Drugs 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- VMWNQDUVQKEIOC-CYBMUJFWSA-N apomorphine Chemical compound C([C@H]1N(C)CC2)C3=CC=C(O)C(O)=C3C3=C1C2=CC=C3 VMWNQDUVQKEIOC-CYBMUJFWSA-N 0.000 description 1
- 229960004046 apomorphine Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 150000003571 thiolactams Chemical class 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Description
Verfahren zur Herstellung basisch substituierter Heterocyclen Die Erfindung betrifft ein Verfahren zur Herstel lung von 11-basisch substituierten Dibenz[b,f]-1,4-oxa- zepinen, Dibenzo[b,f]-1,4-thiazepinen und Dibenzo[- b,el-1,4-diazepinen der Formel:
EMI0001.0008
sowie von Säure-Additionssalzen davon. In Formel<B>1</B> stellt Z ein Sauerstoffatom, ein Schwefelatom oder eine Iminogruppe dar.
R, ist Wasserstoff, niedriges Alkyl, <B>c</B> niedriges Hydroxyalkyl, welches acyllert sein kann, oder Alkoxyalk-vl mit höchstens<B>5</B> C-Atomen.
Unter niedrigem Alkyl usw. wird solches mit<B>1</B> bis<B>3</B> C-Atomen verstanden, Die oewünschten Produkte werden erhalten, wenn man eine Verbindun2 der Formel:
EMI0001.0021
worin Z die genannte Bedeutung hat und X einen mit <B>C</B> C dem Wasserstoff von Aminen abspaltbaren Rest dar- stellt, mit Piperazin bzw. einem Piperazinderivat der Formel:
EMI0001.0026
worin R, die oben angegebene Bedeutung hat, umsetzt.
Als ein mit dem Wasserstoff von Aminen abspalt- barer Rest, welcher kovalent oder gegebenenfalls auch ionisch an das Kohlenstoffatom gebunden sein kann, kommt vorzugsweise ein Halogenatom, die Sulfhydril- gruppe, eine gegebenenfalls aktivierte Alkoxy- oder Alkylmercaptogruppe. beispielsweise die Methoxy-, Thiomethyl- oder p-Nitrobenzylthiogruppe, oder ein Tosvlrest in Betracht.
Äusgangsstoffe der Formel II erhält man beispiels weise durch Cberführen von Lactamen der Formel:
EMI0001.0043
worin Z die -enannte Bedeutung hat, in die Thiolac- tame, aewünschtenfalls unter nachfol-ender Alk-vlie- rung der letzteren, oder durch Umsetzen der Lactame mit einem Halogenierungsmittel,
wie Phosphoroxychlo- rid oder Phosphorpentachlorid, vorzugsweise in Gegen wart katalytischer Nlen en von Dimethylanilin oder <B>9</B> Dimethylformarnid. Lactame der Formel IV sind ihrer seits durch Ringschluss von Verbindungen der For meln:
EMI0002.0001
worin Z die 2enannte Bedeutung hat und R., Wasser stoff oder niedriges Alkyl bedeutet, oder
EMI0002.0004
worin Z die -enannte Bedeutun#z hat und Hal für ein lialo2enatom steht, erhältlich.
Üle in der beschriebenen Weise erhaltenen Basen sind in den nielsten Fällen kristallisierbar, sonst im Hochvakuum unzersetzt destillierbar, und bilden mit anor±!anisclien und or,-,anischen Säuren, beispielsweise Salzsäure, Brornwasserstoffsäure, Schwefelsäure, Salpe tersäure.
Phosphorsäure. Essi2säure, Oxalsäure, Maleinsäure, Weinsäure, Toluolsilfonsäure u. dgl., in Wasser beständiLe Additionssalze. in welcher Form die Produkte ebenfalls verwendet werden können.
Die in der beschriebenen Weise erhaltenen Basen und ihre Säure-Additionssalze sind neue Verbindun- cen. die als Wirkstoffe in Arzneimitteln Verwendung finden. Sie üben eine -,ünsti-,e Wirkun,-, auf das Zen- tralnervens-#,-stem aus und fallen als Neuroleptika. Sedativa und insbesondere als Antiemetika in Betracht.
Die antiemetische Wirkung äussert sich pharmako- lo21sch bei Hunden und Ratten in einem Anta2onismus ce2enüber der Wirkung von Apomorphin. Als beson- C <B>- C</B> ders wirksam hat sich das gemäss Beispiel<B>1</B> erhaltene Z-'\,fethvlsulfonyl-1 1-(4-rnethyl- <B>1</B> -piperazinyl)-dibenz- [b,f]-1,
#-oxa-zepin e#rwiesen.
EMI0002.0046
<I>Tabelle</I>
<tb> Beispiel
<tb> <B>Z <SEP> iz,</B> <SEP> physikalische <SEP> Konstanten
<tb> <B><U>1)</U></B> <SEP> H <SEP> Base: <SEP> <B>Smp. <SEP> 189-191 <SEP> ## <SEP> C</B>
<tb> <B>0</B> <SEP> (aus <SEP> Ac/Ae/Pe)
<tb> <B>3 <SEP> -CH,</B> <SEP> Base: <SEP> Smp. <SEP> <B>219-223' <SEP> C</B>
<tb> <B>s</B> <SEP> (aus <SEP> Ac/Pe)
<tb> H <SEP> Base: <SEP> Smp. <SEP> <B>180-1833 <SEP> C</B>
<tb> <B>S</B> <SEP> (aus <SEP> <B>ChTe)</B>
<tb> <B><I>5</I> <SEP> -CH,</B> <SEP> Dihydrobrorrtid: <SEP> Smp. <SEP> <B>225-230' <SEP> C</B>
<tb> <B>NH</B> <SEP> (Zers.; <SEP> aus <SEP> Me,;Essigf--ster)
<tb> <B>6</B> <SEP> H <SEP> Dihydrobron-#d:
<SEP> Smp. <SEP> <B>233-248- <SEP> C</B>
<tb> <B>NH</B> <SEP> (aus <SEP> MelEssiaester)
<tb> <B>C</B>
<tb> <B>7 <SEP> -CH.,-CH:,</B> <SEP> Base: <SEP> Smp. <SEP> <B>190-1911 <SEP> C</B>
<tb> <B>0</B> <SEP> (aus <SEP> Ac!Pe)
<tb> <B>8 <SEP> -CH.#-CH.,OH</B> <SEP> Base: <SEP> Smp. <SEP> <B>175-177- <SEP> C</B>
<tb> <B>0</B> <SEP> (aus <SEP> Ac/Pe)
<tb> <B>9 <SEP> -CH.,-CH.,OCH:,</B> <SEP> Base:
<SEP> Smp. <SEP> 146-149## <SEP> <B>C</B>
<tb> <B>0</B> <SEP> (aus <SEP> Ac/Pe) <I>Beispiel<B>1</B></I> <B>5 g</B> 2-Methytsulfonyt-1,1 1-dihydro#-1 1--oxo-dibenz [b,2-1,4-o#xazepin (Smp. 242-244--<B>Q</B> werden n-ü <B>1,8</B> ml N,N-Dimethylmüin und<B>50</B> ral Phosphorox# chlorid während<B>5</B> Stunden unter Rückfluss erhitzt worauf das Reaktionsgernisch im Vakuum zur Trockn, eingeengt wird.
Der Rückstand wird mit Xylol versetz und nochmals eingedampft. Hierauf wird der Rück stand in Xylol gelöst und auf Eis gegossen, worau man dreimal mit Xyloi ausschüttelt. Die Xylollösun# wird mit verdünnter Salzsäure, Wasser und wässrige Natriumchloridlösung gewaschen, mit Natriumsulfat ge trocknet. mit Aktivkohle behandelt und durch weni, Aluminiumoxid filtriert.
Das Filtrat wird ein2een(#t un( dann mit 12 m] N-,Ivieth#rlpiperazin während<B>6</B> Stunde: unter Rückfluss erhitzt.
Das ReaktionsLemisch wirc mit Wasser und konzentrierter Natronlauee versetz und zweimal mit Äther ausuleschütteit. Die Ä#herauszü(-l# werden mehrmals mit Wasser Pewaschen und dann Ml' verdünnter Salzsäure ausgescl:Ittelt. Die sauren Aus züge werden alkalisch -,estellt und zweimal mit Äthe: extrahiert.
Die Ätherphasen werden mit Wasser un( wässri-er Natriuinchloridlösun2 -ewaschen, mit Natri- umsulfat 2etrock-liet, mit Aktivkohle behandelt un( durch wenig Aluminiumoxid filtriert. Das Filtrat wirc stark eingedampft und mit Petroläther versetzt.
Die ab geschiedenen Kristalle Nverden in Aceton Oelöst und- c nach starkem Eindampfen der Lösung. auf Zusatz vor Äther/Petroläther umkristallisiert. Man erhält<B>5.8</B><U>L</U> 2-Methylsulfonyl-1 <B>1</B> -(4-methyl-1 -piperazinyl)-dibenz- [b,f]-1,4-oxazepin in Form von schwach gelblichen Nadeln vom Schmelzpunkt 178-179' <B>C.</B>
Bei analogem Vorgehen %vie im vorer%\ähriten Bei spiel erhält man weiterhin die in der nachfoleenden Tabelle erwähnten Produkte entsprechend Formel<B>1. In</B> der Tabelle haben R, und Z die früher genannte Be deutung. In der Kolonne rechts bedeutJ Ac Aceton. Ae Äther, Ch Chloroform. Ni1c Methanol und Pe Petrol- äther.
Process for the Production of Basically Substituted Heterocycles The invention relates to a process for the production of 11-base substituted dibenz [b, f] -1,4-oxazepines, dibenzo [b, f] -1,4-thiazepines and dibenzo [- b, el-1,4-diazepines of the formula:
EMI0001.0008
as well as acid addition salts thereof. In formula <B> 1 </B>, Z represents an oxygen atom, a sulfur atom or an imino group.
R 1 is hydrogen, lower alkyl, lower hydroxyalkyl, which can be acyl-tertiary, or alkoxyalkylene with a maximum of 5 carbon atoms.
Lower alkyl, etc. is understood as meaning those with <B> 1 </B> to <B> 3 </B> carbon atoms. The desired products are obtained when a compound of the formula:
EMI0001.0021
where Z has the meaning mentioned and X is a radical which can be split off from amines with the hydrogen with C, with piperazine or a piperazine derivative of the formula:
EMI0001.0026
wherein R, has the meaning given above, reacts.
A halogen atom, the sulfhydryl group, an optionally activated alkoxy or alkyl mercapto group, can be used as a radical which can be split off from amines with the hydrogen and which can be covalently or optionally also ionically bonded to the carbon atom. for example the methoxy, thiomethyl or p-nitrobenzylthio group, or a tosyl radical.
Starting materials of the formula II are obtained, for example, by converting lactams of the formula:
EMI0001.0043
where Z has the meaning mentioned, into the thiolactams, if desired with subsequent alkification of the latter, or by reacting the lactams with a halogenating agent,
such as phosphorus oxychloride or phosphorus pentachloride, preferably in the presence of catalytic compounds of dimethyl aniline or 9 dimethyl formamide. Lactams of the formula IV are in turn formed by ring closure of compounds of the formulas:
EMI0002.0001
wherein Z has the meaning mentioned and R., hydrogen or lower alkyl is, or
EMI0002.0004
in which Z has the meaning mentioned and Hal stands for a lialo2enatom.
Oils obtained in the manner described are in most cases crystallizable, otherwise they can be distilled without decomposition in a high vacuum, and form with inorganic, anic and or, anic acids, for example hydrochloric acid, hydrobromic acid, sulfuric acid, nitric acid.
Phosphoric acid. Acetic acid, oxalic acid, maleic acid, tartaric acid, toluenesilfonic acid and the like Like., addition salts which are stable in water. in which form the products can also be used.
The bases obtained in the manner described and their acid addition salts are new compounds. which are used as active ingredients in pharmaceuticals. They exert a -, ünsti-, e effect -, on the central nerve - #, - system and fall as neuroleptics. Sedatives and especially as antiemetics into consideration.
The antiemetic effect manifests itself pharmacologically in dogs and rats in an antagonism over the effect of apomorphine. The Z - '\, fethvlsulfonyl-1 1- (4-methyl- <B> 1 </B>) obtained according to Example <B> 1 </B> has proven to be particularly effective. B> -piperazinyl) -dibenz- [b, f] -1,
# -oxa-zepin e # proven.
EMI0002.0046
<I> table </I>
<tb> example
<tb> <B> Z <SEP> iz, </B> <SEP> physical <SEP> constants
<tb> <B><U>1)</U> </B> <SEP> H <SEP> Base: <SEP> <B> Smp. <SEP> 189-191 <SEP> ## <SEP> C </B>
<tb> <B> 0 </B> <SEP> (from <SEP> Ac / Ae / Pe)
<tb> <B> 3 <SEP> -CH, </B> <SEP> Base: <SEP> Smp. <SEP> <B> 219-223 '<SEP> C </B>
<tb> <B> s </B> <SEP> (from <SEP> Ac / Pe)
<tb> H <SEP> Base: <SEP> Smp. <SEP> <B> 180-1833 <SEP> C </B>
<tb> <B> S </B> <SEP> (from <SEP> <B> ChTe) </B>
<tb> <B> <I> 5 </I> <SEP> -CH, </B> <SEP> Dihydrobrorrtid: <SEP> Smp. <SEP> <B> 225-230 '<SEP> C </ B>
<tb> <B> NH </B> <SEP> (dec .; <SEP> from <SEP> Me,; vinegar window)
<tb> <B> 6 </B> <SEP> H <SEP> Dihydrobron- # d:
<SEP> Smp. <SEP> <B> 233-248- <SEP> C </B>
<tb> <B> NH </B> <SEP> (from <SEP> MelEssiaester)
<tb> <B> C </B>
<tb> <B> 7 <SEP> -CH., - CH :, </B> <SEP> Base: <SEP> Smp. <SEP> <B> 190-1911 <SEP> C </B>
<tb> <B> 0 </B> <SEP> (from <SEP> Ac! Pe)
<tb> <B> 8 <SEP> -CH. # - CH., OH </B> <SEP> Base: <SEP> Smp. <SEP> <B> 175-177- <SEP> C </ B >
<tb> <B> 0 </B> <SEP> (from <SEP> Ac / Pe)
<tb> <B> 9 <SEP> -CH., - CH., OCH :, </B> <SEP> Base:
<SEP> Smp. <SEP> 146-149 ## <SEP> <B> C </B>
<tb> <B> 0 </B> <SEP> (from <SEP> Ac / Pe) <I> Example<B>1</B> </I> <B> 5 g </B> 2- Methytsulfonyt-1,1 1-dihydro # -1 1 - oxo-dibenz [b, 2-1,4-o # xazepine (mp. 242-244-- <B> Q </B> are n-ü < B> 1.8 ml of N, N-dimethylmuine and 50 ral Phosphorox chloride heated under reflux for 5 hours, whereupon the reaction mixture was concentrated to dryness in vacuo becomes.
The residue is mixed with xylene and evaporated again. The residue is then dissolved in xylene and poured onto ice, whereupon it is extracted three times with xyloi. The xylene solution is washed with dilute hydrochloric acid, water and aqueous sodium chloride solution and dried with sodium sulfate. treated with activated charcoal and filtered through little aluminum oxide.
The filtrate is heated under reflux for <B> 6 </B> hours (then with 12 m] N-, Ivieth # rlpiperazine.
The reaction mixture is mixed with water and concentrated caustic soda and poured out twice with ether. The extracts are washed several times with water and then extracted with ml of dilute hydrochloric acid. The acid extracts are made alkaline, and extracted twice with ethers.
The ether phases are washed with water and aqueous sodium chloride solution, dried with sodium sulfate, treated with activated charcoal and filtered through a little aluminum oxide. The filtrate is strongly evaporated and petroleum ether is added.
The separated crystals are dissolved in acetone oil and after vigorous evaporation of the solution. recrystallized on addition from ether / petroleum ether. This gives <B> 5.8 </B> <U> L </U> 2-methylsulfonyl-1 <B> 1 </B> - (4-methyl-1 -piperazinyl) -dibenz- [b, f] - 1,4-oxazepine in the form of pale yellowish needles with a melting point of 178-179 '<B> C. </B>
If you proceed in the same way as in the previous example, you still get the products mentioned in the following table according to formula <B> 1. In the table, R and Z have the meanings given earlier. In the column on the right, acetone means acetone. Ae ether, Ch chloroform. Ni1c methanol and Pe petroleum ether.
Claims (1)
Priority Applications (28)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1011567A CH485752A (en) | 1967-07-14 | 1967-07-14 | Process for the preparation of basic substituted heterocycles |
| CH1909269A CH485765A (en) | 1967-07-14 | 1967-07-14 | Process for the preparation of basic substituted heterocycles |
| CH1909469A CH485749A (en) | 1967-07-14 | 1967-07-14 | Process for the preparation of basic substituted heterocycles |
| CH1909369A CH485748A (en) | 1967-07-14 | 1967-07-14 | Process for the preparation of basic substituted heterocycles |
| CH1909569A CH485750A (en) | 1967-07-14 | 1967-07-14 | Process for the preparation of basic substituted heterocycles |
| CH853970A CH514612A (en) | 1967-03-13 | 1968-02-14 | Process for the preparation of 11-basic substituted dibenz (b, f) -1,4-oxazepines and dibenzo (b, e) -1,4-diazepines |
| CH751571A CH517759A (en) | 1967-03-13 | 1968-02-14 | Process for the preparation of 11-basic substituted dibenz (b, f) -1,4-oxazepines and dibenzo (b, e) -1,4-diazepines |
| CH854070A CH499539A (en) | 1967-03-13 | 1968-02-14 | Cns-active 2-aminosulphonyl-11-piperazinyl- - dibenz-1,4-oxo (or thi or-di) azepines prodn |
| IL2957168A IL29571A (en) | 1967-03-13 | 1968-03-04 | 11-substituted dibenzo(b,f)-1,4-oxazepines,dibenzo(b,f)-1,4-thiazepines and dibenzo(b,e)-1,4-diazepines and their preparation |
| DE19681720007 DE1720007A1 (en) | 1967-03-13 | 1968-03-04 | Basically substituted heterocycles |
| AT00206/70A AT292718B (en) | 1967-03-13 | 1968-03-05 | PROCESS FOR THE PRODUCTION OF NEW 11-BASIC SUBSTITUTED DIBENZ<B,F>-1,4-OXAZEPINE, DIBENZO<B,F>-1,4-THIAZEPINE AND DIBENZO<B,E>-1,4-DIAZEPINE AND ACID- ADDITIONAL SALTS THEREOF |
| GB00561/68A GB1216523A (en) | 1967-03-13 | 1968-03-05 | Basically substituted dibenzoxazepines, dibenzothiazepines and dibenzodiazepines |
| AT00204/70A AT292716B (en) | 1967-03-13 | 1968-03-05 | PROCESS FOR THE PRODUCTION OF NEW 11-BASIC SUBSTITUTED DIBENZ<B,F>-1,4-OXAZEPINE, DIBENZO<B,F>-1,4-THIAZEPINE AND DIBENZO<B,E>-1,4-DIAZEPINE AND ACID- ADDITIONAL SALTS THEREOF |
| AT00210/70A AT292722B (en) | 1967-07-14 | 1968-03-05 | PROCESS FOR THE PRODUCTION OF NEW 11-BASIC SUBSTITUTED DIBENZ<B,F>-1,4-OXAZEPINE, DIBENZO<B,F>-1,4-THIAZEPINE AND DIBENZO<B,E>-1,4-DIAZEPINE AND ACID- ADDITIONAL SALTS THEREOF |
| AT00207/70A AT292719B (en) | 1967-07-14 | 1968-03-05 | PROCESS FOR THE PRODUCTION OF NEW 11-BASIC SUBSTITUTED DIBENZ<B,F>-1,4-OXAZEPINE, DIBENZO<B,F>-1,4-THIAZEPINE AND DIBENZO<B,E>-1,4-DIAZEPINE AND ACID- ADDITIONAL SALTS THEREOF |
| AT215368A AT292707B (en) | 1967-03-13 | 1968-03-05 | Process for the production of new 11-basic substituted dibenz [b, f] -1,4-oxazepine, dibenzo [b, f] -1,4-thiazepine and dibenzo [b, e] -1,4-diazepine, as well as acid -Addition salts thereof |
| AT00205/70A AT292717B (en) | 1967-03-13 | 1968-03-05 | PROCESS FOR THE PRODUCTION OF NEW 11-BASIC SUBSTITUTED DIBENZ<B,F>-1,4-OXAZEPINE, DIBENZO<B,F>-1,4-THIAZEPINE AND DIBENZO<B,E>-1,4-DIAZEPINE AND ACID- ADDITIONAL SALTS THEREOF |
| SE03129/68A SE364277B (en) | 1967-03-13 | 1968-03-08 | |
| FR143389A FR8046M (en) | 1967-03-13 | 1968-03-12 | |
| NO94668A NO123459B (en) | 1967-03-13 | 1968-03-12 | |
| BE712114D BE712114A (en) | 1967-03-13 | 1968-03-13 | |
| NL6803570A NL6803570A (en) | 1967-03-13 | 1968-03-13 | |
| US769373A US3539573A (en) | 1967-03-22 | 1968-10-21 | 11-basic substituted dibenzodiazepines and dibenzothiazepines |
| US29279A US3683034A (en) | 1963-09-27 | 1970-04-16 | Process for the preparation of substituted hydroquinones |
| US00060976A US3758479A (en) | 1967-03-22 | 1970-07-06 | Nitro and sulphamoyl substituted dibenzodiazepines |
| US00228747A US3793325A (en) | 1967-03-22 | 1972-02-23 | 11-basically substituted dibenz(b,f)(1,4)thiazepine and dibenz(b,e)(1,4)diazepines |
| US00342399A US3852446A (en) | 1967-03-13 | 1973-03-19 | Organic compounds in treatment of psychotic disturbances |
| US435430A US3908010A (en) | 1967-03-22 | 1974-01-22 | Basically substituted heterocycles as anti-emetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1011567A CH485752A (en) | 1967-07-14 | 1967-07-14 | Process for the preparation of basic substituted heterocycles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH485752A true CH485752A (en) | 1970-02-15 |
Family
ID=4359519
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1909469A CH485749A (en) | 1967-07-14 | 1967-07-14 | Process for the preparation of basic substituted heterocycles |
| CH1909569A CH485750A (en) | 1967-07-14 | 1967-07-14 | Process for the preparation of basic substituted heterocycles |
| CH1909269A CH485765A (en) | 1967-07-14 | 1967-07-14 | Process for the preparation of basic substituted heterocycles |
| CH1909369A CH485748A (en) | 1967-07-14 | 1967-07-14 | Process for the preparation of basic substituted heterocycles |
| CH1011567A CH485752A (en) | 1963-09-27 | 1967-07-14 | Process for the preparation of basic substituted heterocycles |
Family Applications Before (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1909469A CH485749A (en) | 1967-07-14 | 1967-07-14 | Process for the preparation of basic substituted heterocycles |
| CH1909569A CH485750A (en) | 1967-07-14 | 1967-07-14 | Process for the preparation of basic substituted heterocycles |
| CH1909269A CH485765A (en) | 1967-07-14 | 1967-07-14 | Process for the preparation of basic substituted heterocycles |
| CH1909369A CH485748A (en) | 1967-07-14 | 1967-07-14 | Process for the preparation of basic substituted heterocycles |
Country Status (2)
| Country | Link |
|---|---|
| AT (2) | AT292719B (en) |
| CH (5) | CH485749A (en) |
-
1967
- 1967-07-14 CH CH1909469A patent/CH485749A/en not_active IP Right Cessation
- 1967-07-14 CH CH1909569A patent/CH485750A/en not_active IP Right Cessation
- 1967-07-14 CH CH1909269A patent/CH485765A/en not_active IP Right Cessation
- 1967-07-14 CH CH1909369A patent/CH485748A/en not_active IP Right Cessation
- 1967-07-14 CH CH1011567A patent/CH485752A/en not_active IP Right Cessation
-
1968
- 1968-03-05 AT AT00207/70A patent/AT292719B/en not_active IP Right Cessation
- 1968-03-05 AT AT00210/70A patent/AT292722B/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CH485750A (en) | 1970-02-15 |
| CH485748A (en) | 1970-02-15 |
| AT292722B (en) | 1971-08-15 |
| AT292719B (en) | 1971-08-15 |
| CH485765A (en) | 1970-02-15 |
| CH485749A (en) | 1970-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1445845A1 (en) | New benzomorphans and methods of making them | |
| DE1695929C3 (en) | 1 ^ -Dihydro-1-hydroxy ^ -imino ^ -amino-6-methylpyrimidines and a process for their preparation | |
| DE2241012A1 (en) | NEW 3,1-BENZOXAZIN-4-ON DERIVATIVES AND METHOD FOR MANUFACTURING THE SAME | |
| CH485752A (en) | Process for the preparation of basic substituted heterocycles | |
| DE1470416A1 (en) | Process for the preparation of II-basic substituted 5 H-dibenzo [b, e], [1,4] diazepines | |
| DE1470367A1 (en) | Process for the preparation of 5,6-dihydro-6-oxopyrido [2,3-b] [1,4] benzoxazepines substituted in the 5-position | |
| DE1470427C3 (en) | Substituted 6-piperazino-morphanthridines | |
| DE1097995B (en) | Process for the preparation of phenthiazine derivatives | |
| DE2352107A1 (en) | NEW CHEMICAL COMPOUNDS, THEIR PRODUCTION METHODS AND APPLICATIONS OF THESE COMPOUNDS, IN PARTICULAR TO THE SYNTHESIS 2,4-DIAMINO- (3 ', 4', 5'-TRIMETHOXY-) 1-BENZYL-PYRIMIDINE | |
| DE1795053A1 (en) | Process for the preparation of compounds of the benzodiazepine series | |
| AT308754B (en) | Process for the preparation of benzodiazepine derivatives and acid addition salts thereof | |
| AT292717B (en) | PROCESS FOR THE PRODUCTION OF NEW 11-BASIC SUBSTITUTED DIBENZ<B,F>-1,4-OXAZEPINE, DIBENZO<B,F>-1,4-THIAZEPINE AND DIBENZO<B,E>-1,4-DIAZEPINE AND ACID- ADDITIONAL SALTS THEREOF | |
| DE2012943A1 (en) | Novel triazole derivatives and processes for making the same | |
| DE1300954B (en) | Process for the production of dibenzothiepin and oxepines | |
| CH495372A (en) | Substd. dibenzo(b,f) 1,4 oxazepine and thiazepine (4 oxides) - as neuroleptics | |
| DE1445858C3 (en) | 7-cyano-5-phenyl-1,2-dihydro-3H-1,4benzodiazepin-2-one derivatives | |
| AT269371B (en) | Process for the production of new N-substituted normorphines | |
| AT269372B (en) | Process for the production of new N-substituted benzomorphans | |
| AT211823B (en) | Process for the preparation of new aryloxyacetic acid amides | |
| DE1470009C (en) | 3.5 dihydro 5 phenyl 4.1 benzoxaze pin 2 ones | |
| DE1545805B2 (en) | Process for the preparation of benzothiazine derivatives | |
| AT225193B (en) | Process for the preparation of new 2,4-diamino-pyrido- (2,3-d) -pyrimidines | |
| AT337173B (en) | PROCESS FOR THE PRODUCTION OF NEW ISOINDOLINE DERIVATIVES AND THEIR SALT | |
| AT203013B (en) | Process for the preparation of new N-aminoalkyl derivatives of azepines | |
| AT260935B (en) | Process for the preparation of new 5,6-dihydro-5-oxo-11H-pyrido [2,3-b] [1,5] benzodiazepines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |